Plain-English translation of NCT07281898 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a catheter ablation procedure for paroxysmal atrial fibrillation (a heart rhythm condition where irregular heartbeats start suddenly and stop on their own). The standard treatment burns scar tissue around the pulmonary veins in your heart. This study is testing whether adding burst pacing—a technique that temporarily stimulates your heart to trigger extra heartbeats—and then burning additional patterns in your heart tissue can improve outcomes and prevent the condition from coming back.
Even after standard ablation treatment, about 30–50% of patients experience atrial fibrillation again within a year. Doctors believe that triggering extra heartbeats during the procedure and then treating the patterns that emerge might help prevent recurrence, but this needs to be tested in a rigorous study.
You likely qualify if…
You likely don't qualify if…
You will undergo a catheter ablation procedure performed by a cardiologist. During the procedure, doctors will use standard techniques to isolate the pulmonary veins and another vein called the superior vena cava. If you are randomized to the treatment group, doctors will also use burst pacing to trigger extra heartbeats and then perform additional targeted ablation based on the patterns observed. The entire procedure typically takes a few hours. You will then be followed up regularly for at least 12 months to monitor whether your atrial fibrillation returns.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
China